N-Acetylcysteine Alleviates the Progression of Chronic Kidney Disease: A Three-Year Cohort Study

Background and Objectives: The prevalence of chronic kidney disease (CKD) is approximately 10% of the population in many countries. CKD progresses to end-stage renal disease (ESRD), resulting in adverse outcomes, prolonged hospitalization, and increased healthcare costs. Therefore, reducing CKD prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Ai-Hua, Wang, Chih-Jen, Lin, Ya-Ling, Wang, Chia-Liang, Chiang, Tsay-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673586/
https://www.ncbi.nlm.nih.gov/pubmed/38004033
http://dx.doi.org/10.3390/medicina59111983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673586/
https://www.ncbi.nlm.nih.gov/pubmed/38004033
http://dx.doi.org/10.3390/medicina59111983

Ejemplares similares